oxprenolol has been researched along with Cardiac Hypertrophy in 7 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the beta-blocking agents propranolol and oxprenolol on isoproterenol-induced cardiac hypertrophy has been investigated in the rat." | 7.65 | Prevention of isoproterenol-induced cardiac hypertrophy by beta-blocking agents in the rat. ( Csáky, L; Nosztray, K; Szabó, J; Szegi, J, 1976) |
| "The effect of the beta-blocking agents propranolol and oxprenolol on isoproterenol-induced cardiac hypertrophy has been investigated in the rat." | 3.65 | Prevention of isoproterenol-induced cardiac hypertrophy by beta-blocking agents in the rat. ( Csáky, L; Nosztray, K; Szabó, J; Szegi, J, 1976) |
| "Oxprenolol treatment did not modify the blood pressure levels in the renal hypertensive rats nor in the spontaneously hypertensive turkeys." | 1.28 | Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension. ( Dal Palù, C; Pauletto, P; Pessina, AC; Scannapieco, G; Vescovo, G, 1990) |
| "To evaluate the effects of the chronic administration of the fixed combination slow-release, oxprenolol 160 mg and chlorthalidone 20 mg on left ventricular hypertrophy, ten hypertensive out-patients, with left ventricular hypertrophy documented by left ventricular mass index (LVMI) greater than 130 g/m2, were studied." | 1.27 | Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study. ( Alberti, D; Bertoni, T; De Ambroggi, L; Francucci, BM; Peloso, A, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Idikio, H | 1 |
| Fernandez, PG | 1 |
| Triggle, CR | 1 |
| Kim, BK | 1 |
| Petkov, O | 1 |
| Szabó, J | 1 |
| Nosztray, K | 1 |
| Csáky, L | 1 |
| Szegi, J | 1 |
| Pauletto, P | 1 |
| Vescovo, G | 1 |
| Scannapieco, G | 1 |
| Pessina, AC | 1 |
| Dal Palù, C | 1 |
| Sau, F | 2 |
| Seguro, C | 2 |
| Pili, G | 1 |
| Basciu, M | 1 |
| Siddi, PP | 1 |
| Tamponi, R | 1 |
| Cherchi, A | 2 |
| Alberti, D | 2 |
| Bertoni, T | 1 |
| Peloso, A | 1 |
| Francucci, BM | 1 |
| De Ambroggi, L | 1 |
1 trial available for oxprenolol and Cardiac Hypertrophy
| Article | Year |
|---|---|
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidon | 1990 |
6 other studies available for oxprenolol and Cardiac Hypertrophy
| Article | Year |
|---|---|
Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart Ventricles; Hydrochlorothiazide; Hypertens | 1983 |
Some functional changes in experimentally induced cardiac overload.
Topics: Aminooxyacetic Acid; Animals; Atropine; Cardiomegaly; Disease Models, Animal; Drug Combinations; Ele | 1983 |
Prevention of isoproterenol-induced cardiac hypertrophy by beta-blocking agents in the rat.
Topics: Animals; Cardiomegaly; DNA; Isoproterenol; Muscle Proteins; Myocardium; Oxprenolol; Propranolol; Rat | 1976 |
Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Calcium-Transporting ATPases; Cardiomeg | 1990 |
[Reduction of left ventricular hypertrophy and increased tolerance to exertion in hypertensive patients after antihypertensive therapy with slow-release oxprenolol and chlorthalidone].
Topics: Adult; Cardiomegaly; Chlorthalidone; Delayed-Action Preparations; Drug Therapy, Combination; Exercis | 1986 |
Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiomegaly; Chlorthalidone; Creatinine; Delayed-Action | 1988 |